Henry Schein, Inc. (NASDAQ:HSIC) Given Average Rating of “Moderate Buy” by Brokerages

Henry Schein, Inc. (NASDAQ:HSIC) has been given an average rating of “Moderate Buy” by the eleven brokerages that are presently covering the firm, MarketBeat Ratings reports. Six research analysts have rated the stock with a hold recommendation, four have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 year price target among analysts that have issued ratings on the stock in the last year is $78.89.

A number of equities research analysts have recently issued reports on the stock. Mizuho assumed coverage on shares of Henry Schein in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 target price on the stock. StockNews.com raised Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Barrington Research reiterated an “outperform” rating and issued a $82.00 target price on shares of Henry Schein in a research report on Wednesday, November 6th. Finally, Evercore ISI upped their price target on Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research report on Tuesday, October 8th.

Insider Activity

In other news, COO Michael S. Ettinger sold 12,240 shares of Henry Schein stock in a transaction dated Monday, November 18th. The stock was sold at an average price of $75.00, for a total value of $918,000.00. Following the transaction, the chief operating officer now directly owns 87,706 shares in the company, valued at approximately $6,577,950. The trade was a 12.25 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 1.14% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in HSIC. Cromwell Holdings LLC boosted its position in shares of Henry Schein by 93.4% in the third quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock valued at $26,000 after acquiring an additional 170 shares during the period. Studio Investment Management LLC grew its position in Henry Schein by 3.8% in the 3rd quarter. Studio Investment Management LLC now owns 4,674 shares of the company’s stock worth $341,000 after purchasing an additional 172 shares during the last quarter. Simplify Asset Management Inc. increased its holdings in shares of Henry Schein by 5.0% during the 2nd quarter. Simplify Asset Management Inc. now owns 3,695 shares of the company’s stock worth $237,000 after purchasing an additional 175 shares during the period. Huntington National Bank raised its position in shares of Henry Schein by 16.8% during the third quarter. Huntington National Bank now owns 1,515 shares of the company’s stock valued at $110,000 after buying an additional 218 shares during the last quarter. Finally, Tempus Wealth Planning LLC lifted its stake in shares of Henry Schein by 6.0% in the second quarter. Tempus Wealth Planning LLC now owns 4,607 shares of the company’s stock valued at $295,000 after buying an additional 260 shares during the period. 96.62% of the stock is owned by institutional investors.

Henry Schein Price Performance

Shares of HSIC stock opened at $75.14 on Tuesday. The firm has a fifty day simple moving average of $72.36 and a 200-day simple moving average of $70.10. The company has a market capitalization of $9.37 billion, a PE ratio of 30.92, a price-to-earnings-growth ratio of 2.31 and a beta of 0.87. Henry Schein has a twelve month low of $63.67 and a twelve month high of $82.63. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, beating the consensus estimate of $1.17 by $0.05. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company had revenue of $3.17 billion during the quarter, compared to analysts’ expectations of $3.24 billion. During the same period in the prior year, the business posted $1.32 EPS. The business’s revenue was up .4% on a year-over-year basis. Equities research analysts anticipate that Henry Schein will post 4.78 earnings per share for the current fiscal year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.